JP2015509971A5 - - Google Patents

Download PDF

Info

Publication number
JP2015509971A5
JP2015509971A5 JP2014561471A JP2014561471A JP2015509971A5 JP 2015509971 A5 JP2015509971 A5 JP 2015509971A5 JP 2014561471 A JP2014561471 A JP 2014561471A JP 2014561471 A JP2014561471 A JP 2014561471A JP 2015509971 A5 JP2015509971 A5 JP 2015509971A5
Authority
JP
Japan
Prior art keywords
gtx
psp
pharmaceutical composition
mammal
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014561471A
Other languages
English (en)
Japanese (ja)
Other versions
JP6196638B2 (ja
JP2015509971A (ja
Filing date
Publication date
Priority claimed from EP12159932.8A external-priority patent/EP2638908A1/en
Application filed filed Critical
Publication of JP2015509971A publication Critical patent/JP2015509971A/ja
Publication of JP2015509971A5 publication Critical patent/JP2015509971A5/ja
Application granted granted Critical
Publication of JP6196638B2 publication Critical patent/JP6196638B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014561471A 2012-03-16 2013-03-15 麻痺性貝毒 Active JP6196638B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP12159932.8 2012-03-16
EP12159932.8A EP2638908A1 (en) 2012-03-16 2012-03-16 Paralytic Shellfish Poison
US201261613601P 2012-03-21 2012-03-21
US61/613,601 2012-03-21
PCT/EP2013/055448 WO2013135884A1 (en) 2012-03-16 2013-03-15 Paralytic shellfish poison

Publications (3)

Publication Number Publication Date
JP2015509971A JP2015509971A (ja) 2015-04-02
JP2015509971A5 true JP2015509971A5 (https=) 2016-04-28
JP6196638B2 JP6196638B2 (ja) 2017-09-13

Family

ID=45874715

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014561471A Active JP6196638B2 (ja) 2012-03-16 2013-03-15 麻痺性貝毒

Country Status (12)

Country Link
US (1) US9593120B2 (https=)
EP (2) EP2638908A1 (https=)
JP (1) JP6196638B2 (https=)
KR (1) KR20140138958A (https=)
CN (1) CN104363915A (https=)
AU (1) AU2013234287B2 (https=)
BR (1) BR112014022921B8 (https=)
CA (1) CA2866795C (https=)
ES (1) ES2645999T3 (https=)
PL (1) PL2825172T3 (https=)
RU (1) RU2633637C2 (https=)
WO (1) WO2013135884A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105259292B (zh) * 2015-11-12 2017-03-22 上海市农业科学院 一种测定水产品中麻痹性贝类毒素的方法
GB201602576D0 (en) 2016-02-12 2016-03-30 Bergen Teknologioverforing As Process
CN108949847B (zh) * 2018-08-01 2021-06-18 浙江海洋大学 一种利用海洋细菌发酵制备膝沟藻毒素的方法
CN109061031A (zh) * 2018-08-15 2018-12-21 浙江海洋大学 微小亚历山大藻代谢产物-膝沟藻毒素的分离纯化方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2775594B1 (fr) * 1998-03-06 2002-12-27 Oreal Utilisation d'un compose inhibant l'activite d'un canal sodium ou d'un canal calcium dans une composition a usage topique
WO2005110417A1 (en) * 2004-05-07 2005-11-24 Phytotox Limited Phycotoxins and uses thereof
JP2007538010A (ja) * 2004-05-07 2007-12-27 ファイトトックス リミテッド フィコトキシンの経皮投与
CN1323081C (zh) * 2005-01-19 2007-06-27 南开大学 二步树脂法制备河豚毒素的方法及河豚毒素制剂
US20060194759A1 (en) * 2005-02-25 2006-08-31 Eidelson Stewart G Topical compositions and methods for treating pain and inflammation
CA2652669A1 (en) * 2006-06-09 2007-12-21 Merck & Co., Inc. Benzazepinones as sodium channel blockers
WO2010111777A1 (en) * 2009-03-30 2010-10-07 Wex Medical Limited Novel sodium channel blocking compounds tetrodotoxin galactopyranosides
AR077252A1 (es) * 2009-06-29 2011-08-10 Xenon Pharmaceuticals Inc Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
US20110086899A1 (en) * 2009-10-14 2011-04-14 Xenon Pharmaceuticals Inc. Pharmaceutical compositions for oral administration
ES2484315T3 (es) * 2010-02-10 2014-08-11 Phytotox Limited Tratamiento de la pérdida del sentido del tacto con derivados de saxitoxina

Similar Documents

Publication Publication Date Title
JP7187522B2 (ja) 勃起不全および他の適応症の処置
JP4991520B2 (ja) 免疫応答調節剤製剤および方法
US20120181201A1 (en) Topical Formulation Containing a Tetracycline and a Method of Treating Skin Infections Using the Same
JP2015509971A5 (https=)
KR20180037228A (ko) 항박테리아 치료제 및 예방제
JP6523311B2 (ja) 局所投与用薬学的組成物
JP2007511544A (ja) アミロイド症の予防若しくは治療のための組成物および方法
JP5732471B2 (ja) 溶媒混合物およびビタミンd誘導体から成る医薬品組成物または類似体
JP2019501861A (ja) 水不溶性またはわずかに水溶性の薬剤の水可溶性を改善するための方法
MX2014013714A (es) Composicion farmaceutica.
JP2017081920A (ja) サキシトキシン誘導体での触覚の喪失の処置
CN107249691A (zh) 用于肺结核治疗的多药疗法
JP2013519653A5 (https=)
JP2021506967A (ja) 痛風を治療するための尿酸一ナトリウムの溶解
JP2016514141A5 (https=)
RU2014141341A (ru) Паралитический яд моллюсков
KR20090047552A (ko) 진균 감염증을 치료하기 위한 제약 조성물
AR085273A1 (es) Formulacion liquida libre de propelente que comprende una droga antimuscarinica
JP2022553175A (ja) がんの処置における使用のためのα-メチル-DL-チロシンのアルキルエステル
US20090012051A1 (en) External preparation
EP1734945A1 (en) A composition containing a complex comprising a metal ion and a carboxylate ligand having anti-inflammatory activity
EP4637742A1 (en) Compositions and methods for treating anhedonia
US20240390366A1 (en) Formulation and method for topical treatment of mycobacterium ulcerans in buruli ulcers
HK1177696B (en) Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue
TH102419A (th) อนุพันธ์ควิโนลีนต่อต้านแบคทีเรีย